Armata Pharmaceuticals (ARMP) Change in Accured Expenses (2016 - 2018)
Historic Change in Accured Expenses for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$371000.0.
- Armata Pharmaceuticals' Change in Accured Expenses fell 5267.49% to -$371000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $144000.0, marking a year-over-year increase of 11718.38%. This contributed to the annual value of -$3.8 million for FY2024, which is 25424.53% down from last year.
- As of Q4 2018, Armata Pharmaceuticals' Change in Accured Expenses stood at -$371000.0, which was down 5267.49% from $123000.0 recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Change in Accured Expenses registered a high of $1.3 million during Q3 2014, and its lowest value of -$1.6 million during Q4 2014.
- In the last 5 years, Armata Pharmaceuticals' Change in Accured Expenses had a median value of $62500.0 in 2016 and averaged -$54622.8.
- As far as peak fluctuations go, Armata Pharmaceuticals' Change in Accured Expenses plummeted by 28037.49% in 2014, and later soared by 2585000.0% in 2017.
- Armata Pharmaceuticals' Change in Accured Expenses (Quarter) stood at -$1.6 million in 2014, then skyrocketed by 114.46% to $236543.0 in 2015, then fell by 19.68% to $190000.0 in 2016, then tumbled by 227.89% to -$243000.0 in 2017, then crashed by 52.67% to -$371000.0 in 2018.
- Its last three reported values are -$371000.0 in Q4 2018, $123000.0 for Q3 2018, and $747000.0 during Q2 2018.